Ausgabe 2/2017
Inhalt (13 Artikel)
Immuno-Oncology: The Third Paradigm in Early Drug Development
Juan Martin-Liberal, Cinta Hierro, Maria Ochoa de Olza, Jordi Rodon
The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities
Nicole J. Flynn, Rajasekharan Somasundaram, Kimberly M. Arnold, Jennifer Sims-Mourtada
Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
Salvatore Corallo, Ettore D’Argento, Antonia Strippoli, Michele Basso, Santa Monterisi, Sabrina Rossi, Alessandra Cassano, Carlo M. Barone
miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives
Mateusz Florczuk, Adam Szpechcinski, Joanna Chorostowska-Wynimko
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Joleen M. Hubbard, Michelle R. Mahoney, William S. Loui, Lewis R. Roberts, Thomas C. Smyrk, Zoran Gatalica, Mitesh Borad, Shaji Kumar, Steven R. Alberts
Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy
Yu Jin Lim, Jaemoon Koh, Kyubo Kim, Eui Kyu Chie, Sehui Kim, Kyoung Bun Lee, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang
Risk of Second Primary Malignancies in Lung Cancer Survivors – The Influence of Different Treatments
Vincent Yi-Fong Su, Chia-Jen Liu, Yuh-Min Chen, Teh-Ying Chou, Tzeng-Ji Chen, Sang-Hue Yen, Tzeon-Jye Chiou, Jin-Hwang Liu, Yu-Wen Hu
Splenic Enlargement and Bone Marrow Hyperplasia in Patients Receiving Trastuzumab-Emtansine for Metastatic Breast Cancer
Michael Kosmin, Andreas Makris, Noorulhuda Jawad, David Woolf, David Miles, Anwar R. Padhani
Anti-PD-L1 atezolizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Literature
Laura Hickmott, Hugo De La Peña, Helen Turner, Fathelrahman Ahmed, Andrew Protheroe, Ashley Grossman, Avinash Gupta
Obinutuzumab: A Review in Rituximab-Refractory or -Relapsed Follicular Lymphoma
Sohita Dhillon
Erratum to: A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines
Yi Shi, Lin Sun, Ge Chen, Dongyan Zheng, Li Li, Wanguo Wei